Meta-Analysis of Complete Remission Rates Following First-Line Salvage Treatment after Anti-CD19 CAR-T Failure in Adult Patients with Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

被引：0
|
作者：
Tomasik, Jaromir [1 ]
Bilicki, Dominik [1 ]
Basak, Grzegorz [1 ]
机构：
[1] Med Univ Warsaw, Dept Hematol Transplantat & Internal Med, Warsaw, Poland
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-204502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1421 / 1422
页数：2
相关论文
共 50 条
  • [31] ANTI-CD19 BITE BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE AND PROLONGS OVERALL SURVIVAL IN ADULT PATIENTS WITH RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Topp, M.
    Goekbuget, N.
    Zugmaier, G.
    Viardot, A.
    Stelljes, M.
    Neumann, S.
    Horst, H. A.
    Reichle, A.
    Marks, R.
    Ganser, A.
    Faul, C.
    Brueggemann, M.
    Ritgen, M.
    Klappers, P.
    Mergen, N.
    Goebeler, M. E.
    Einsele, H.
    Hoelzer, D.
    Bargou, R.
    HAEMATOLOGICA, 2012, 97 : 462 - 462
  • [32] C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical study
    Li, Ping
    Liu, Wei
    Zhou, Lili
    Ye, Shiguang
    Zhu, Dan
    Huang, Jiaqi
    Li, Jing
    Zheng, Chengxiao
    Zhu, Shigui
    Yao, Xin
    Zhu, Kevin
    Yao, Yihong
    Qiu, Lugui
    Liang, Aibin
    Zou, Dehui
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2306 - 2312
  • [33] CAR-T CELL DYNAMICS ARE ASSOCIATED WITH CLINICAL OUTCOME IN PATIENTS TREATED WITH ANTI-CD19 CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL MALIGNANCIES: A REAL-LIFE COHORT STUDY
    Noviello, Maddalena
    De Felice, Francesco
    Bergonzi, Gregorio Maria
    Valtolina, Veronica
    Angelillo, Piera
    Greco, Raffaella
    Xue, Elisabetta
    Campodonico, Edoardo
    Lupo-Stanghellini, Maria Teresa
    Somai, Francesca
    Falcone, Laura
    Beretta, Valeria
    Tassi, Elena
    Peccatori, Jacopo
    Casucci, Monica
    Carrabba, Matteo
    Ciceri, Fabio
    Bonini, Chiara
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 206 - 207
  • [34] Potent anti-leukemia activities of humanized CD19-targeted CAR-T cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, J.
    Wang, G.
    Zheng, J.
    Xu, K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1719 - 1720
  • [35] Anti-CD19 BiTE® blinatumomab induces high complete remission rates in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL) including relapse after stem cell transplantation (SCT)
    Topp, M.
    Goekbuget, N.
    Zugmaier, G.
    Viardot, A.
    Stelljes, M.
    Neumann, S.
    Horst, H. A.
    Reichle, A.
    Marks, R.
    Faul, C.
    Brueggemann, M.
    Ritgen, M.
    Klappers, P.
    Mergen, N.
    Goebeler, M. -E.
    Einsele, H.
    Hoelzer, D.
    Bargou, R.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S40 - S41
  • [36] Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients
    Wang, Ying
    Li, Hujun
    Song, Xuguang
    Qi, Kunming
    Cheng, Hai
    Cao, Jiang
    Shi, Ming
    Yan, Zhiling
    Jing, Guangjun
    Pan, Bin
    Sang, Wei
    Wang, Xiangmin
    Zhao, Kai
    Chen, Chong
    Chen, Wei
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (02) : 250 - 258
  • [37] Systematic Review and Meta-analysis of CD19-Specific CAR-T Cell Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia in the Pediatric and Young Adult Population: Safety and Efficacy Outcomes
    Aamir, Sobia
    Anwar, Muhammad Yasir
    Khalid, Farhan
    Khan, Sana Irfan
    Ali, Muhammad Ashar
    Khattak, Zoia Ehsan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : E334 - E347
  • [38] Allogeneic Hematopoietic Stem Cell Transplantation Following Anti-CD19 BiTE® Blinatumomab in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
    Stein, Anthony
    Topp, Max S.
    Goekbuget, Nicola
    Bargou, Ralf C.
    Dombret, Herve
    Fielding, Adele K.
    Larson, Richard A.
    Rambaldi, Alessandro
    Schiller, Gary
    Zugmaier, Gerhard
    Jia, Catherine
    Maniar, Tapan
    Huber, Birgit
    Nagorsen, Dirk
    Kantarjian, Hagop
    Forman, Stephen J.
    BLOOD, 2014, 124 (21)
  • [39] CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Davila, Marco L.
    Brentjens, Renier J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 802 - 808
  • [40] Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma
    Kedmi, Meirav
    Shouval, Roni
    Fried, Shalev
    Bomze, David
    Fein, Joshua
    Cohen, Zachary
    Danilesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Besser, Michal
    Shimoni, Avichai
    Nagler, Arnon
    Avigdor, Abraham
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 251 - 257
12345